Cargando…
Gender‐specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional states
BACKGROUND AND AIMS: Depression and anxiety are often comorbid with alcoholism and contribute to craving and relapse. We aimed to estimate the prevalence of life‐time diagnoses of major depressive disorder (MDD), substance‐induced depression (SID), anxiety disorder (AnxD) and substance‐induced anxie...
Autores principales: | Karpyak, Victor M., Biernacka, Joanna M., Geske, Jennifer R., Abulseoud, Osama A., Brunner, Michael D., Chauhan, Mohit, Hall‐Flavin, Daniel K., Lewis, Kriste A., Loukianova, Larissa L., Melnyk, George J., Onsrud, David A., Proctor, Brian D., Schneekloth, Terry D., Skime, Michelle K., Wittkopp, John E., Frye, Mark A., Mrazek, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940218/ https://www.ncbi.nlm.nih.gov/pubmed/27009547 http://dx.doi.org/10.1111/add.13386 |
Ejemplares similares
-
Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
por: Karpyak, V M, et al.
Publicado: (2014) -
Replication of Genome Wide Association Studies of Alcohol Dependence: Support for Association with Variation in ADH1C
por: Biernacka, Joanna M., et al.
Publicado: (2013) -
Corrigendum to “Genetic predisposition to major depressive disorder differentially impacts alcohol consumption and high-risk drinking situations in men and women with alcohol use disorder” [Drug Alcohol Depend. 243 (2023) 109753]
por: Karpyak, Victor M., et al.
Publicado: (2023) -
No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users
por: Rydberg, Ann, et al.
Publicado: (2023) -
Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study
por: Ho, Ming‐Fen, et al.
Publicado: (2022)